Branden Vuolo in New York, New York

Home New York New York

Branden Vuolo has Physician Assistant as his primary medical specialty. Their primary office is: 111 Broadway in New York, New York. There is an additional office location, for a total of two, for Branden Vuolo that can be viewed further down.

They're a part of the: New York University medical group which has around 4,291 members. You can call their office at 212-263-9700 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2013 (around 11 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Branden R Vuolo Office Phone and Directions

Branden Vuolo
New York University
111 Broadway
New York, New York 10006
212-263-9700

Patient Ratings
Please rate your experience with Branden Vuolo below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 212-263-9700

Enter a starting address:

Healthcare Info for Branden Vuolo

Medical School: Sorry, his university is not listed
Graduation Year: 2013
The Primary Medical Specialty for Branden Vuolo is listed as: Physician Assistant
Approximate Years of Experience: 11
PAC (PECOS ID)#: 8729208871
NPI #: 1245666247
NPI Created On: 09/23/2013
NPI Last Updated Listed as: 09/02/2022
Primary Taxonomy Code: 363AS0400X
License Number:
016620
Listed Gender: Male

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788033741

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30